Opportunity Information: Apply for TI 11 007
Apply for TI 11 007
- The Substance Abuse Mental Health Services Adminis. in the health sector is offering a public funding opportunity titled "Cooperative Agreement for a Prescriber s Clinical Support System for the Appropriate Use of Opioids in the Treatment of Pain and Opioid related Addiction" and is now available to receive applicants.
- Interested and eligible applicants and submit their applications by referencing the CFDA number(s): 93.243 Substance Abuse and Mental Health ServicesProjects of Regional and National Significance.
- This funding opportunity was created on Mar 9, 2011 and posted on Mar 9, 2011.
- Applicants must submit their applications by Apr 19, 2011. (Agency may still review applications by suitable applicants for the remaining/unused allocated funding in 2026.)
- The funding agency has allocated a total of $500,000.00 to eligible and selected applicants.
- Each selected applicant is eligible to receive up to $500,000.00 in funding.
- The number of recipients for this funding is limited to 1 candidate(s).
- Eligible applicants include: Others (see text field entitled Additional Information on Eligibility for clarification).
- There is a serious public health issue involving the abuse, misuse, non medical use and concomitant morbidity and mortality associated with the increased availability of opioids for the treatment of acute pain, chronic pain and opioid related addiction. While these medications are obtained through theft and other forms of diversion, SAMHSA surveys indicate that opioids used non medically are usually obtained through prescriptions. The Federal Controlled Substance Act permits physicians (including specialties such as psychiatrists, osteopaths, family practice, etc.), mid level practitioners (such as nurse practitioners and physicians assistants), dentists, and other health professionals, to register to prescribe and dispense controlled opioid medications for the treatment of pain, and in limited cases, dependence. Collectively, the quantity of these controlled opioids prescribed by physicians, dentists, and others, has increased several fold over the last decade. There are concerns that opioid prescribing practices may be contributing to the availability of opioid analgesics in the illicit market. In addition, SAMHSA recognizes the difficulty in assessing patients for appropriate opioid prescribing and the limited training that physicians, psychiatrists, and dentists may receive during their formal, specialized training. Moreover, licensed physicians and dentists, who have completed their formal training, lack adequate mentoring, continuing medical education, and other resources to evaluate patients and prescribe opioid analgesics appropriately. To address this public health problem in a timely manner, SAMHSA is limiting eligibility for this cooperative agreement to the American Society of Addiction Medicine, the American Academy of Addiction Psychiatry, the American Medical Association, the American Osteopathic Association, the American Psychiatric Association, and the American Dental Association. These organizations have extensive experience in providing educational and other support services to their members. As such, SAMHSA believes they are uniquely qualified to meet the requirements outlined in this announcement because they have the experience, infrastructure and capacity in place to expeditiously begin program activities. Any of these entities may apply individually they may also apply as a consortium comprised of all or several of the eligible organizations. If a consortium is formed for this purpose, a single organization in the consortium must be the legal applicant, the recipient of the award, and the entity legally responsible for satisfying the grant requirements. If a consortium submits an application, the application must include a written agreement outlining the roles and responsibilities of each organization participating in the consortium. This agreement must be signed by an authorized official of each member of the consortium and attached to the application in Attachment 3 of the RFA, Roles and Responsibilities of Participating Consortium Organizations.
[Watch] Creating a grant proposal using the step-by-step wizard inside the applicant portal:
Opportunity Summary:
This FY 2011 SAMHSA/CSAT cooperative agreement (TI-11-007) funds the creation of a free, nationwide Prescriber's Clinical Support System focused on the appropriate use of opioids in both chronic pain care and opioid-related addiction treatment. The central idea is to build a national mentoring and clinical support network that prescribers and other clinicians can turn to for practical help: current clinical updates, case-based consultations, training, and dissemination of evidence-based outcomes and practices. SAMHSA frames the opportunity as a direct response to rising opioid-related morbidity and mortality, including fatal drug interactions, and to the growing volume of opioid prescribing over the prior decade. The program is positioned within SAMHSA's Prevention of Substance Abuse and Mental Illness Strategic Initiative and aligns with Healthy People 2020 focus area 40 (Substance Abuse).
A major driver described in the announcement is concern about methadone-related deaths and the complicated public narrative around why they are increasing. SAMHSA notes that available data suggest much of the increase in methadone-associated mortality is linked to the rapid growth of methadone prescribing for chronic pain, while public perception often blames diversion from opioid treatment programs (OTPs) or poor care within some OTPs. That perception, according to SAMHSA, risks undermining confidence in methadone maintenance treatment, which the agency emphasizes has strong scientific support as an effective treatment for opioid addiction. In that context, SAMHSA argues it has both an interest in and responsibility for helping ensure methadone is used appropriately whether it is prescribed for pain or dispensed for opioid dependence, and that clinicians have access to the latest evidence-based guidance.
Although methadone is highlighted, the grant is explicitly broader than methadone alone. SAMHSA cites national surveillance sources such as the National Survey on Drug Use and Health and the Drug Abuse Warning Network to underscore rising misuse of other prescription opioids (for example oxycodone, hydrocodone, fentanyl, and oxymorphone). These medications are primarily indicated for pain (not addiction treatment) and are prescribed across a wide range of practitioner types. The opportunity acknowledges that assessing patients for opioid therapy, managing risk, and delivering opioid-based treatment safely are complex tasks, and that many clinicians receive limited formal training and later have limited access to mentoring, continuing education, and real-time clinical support. The PCSS Opioids effort is intended to fill that gap with accessible, no-cost support that can improve prescribing and clinical decision-making and, in turn, reduce misuse, diversion, adverse events, and deaths.
The target audience for the support system includes physicians and dentists, as well as other health professionals involved in opioid prescribing and care, including clinicians working in SAMHSA-certified OTPs and prescribers providing opioid-based therapy for chronic pain. In practical terms, the funded project is expected to stand up a national infrastructure that clinicians can use for training and consultation, backed by evidence-based content and outcomes, and to do so at a scale appropriate for a national public health response. The announcement also situates the work within SAMHSA's broader interagency collaboration on opioid harms, referencing coordination with the Office of National Drug Control Policy, CDC, DEA, NIDA, FDA, and state agencies, and notes that demand for training and consultation from states and practitioners has been increasing.
From a funding and administrative standpoint, this is a discretionary cooperative agreement with an expected single award. Estimated total funding is $500,000, with an award ceiling of $500,000 and no cost-sharing or matching requirement. Key dates listed are a posted date of March 9, 2011 and an application closing date of April 19, 2011 (with an archive date of May 19, 2011). The CFDA number is 93.243 (Substance Abuse and Mental Health Services - Projects of Regional and National Significance).
Eligibility is deliberately narrow due to SAMHSA's stated need to move quickly with organizations that already have the reach, infrastructure, and credibility to educate large numbers of prescribers. Applicants are limited to the American Society of Addiction Medicine, the American Academy of Addiction Psychiatry, the American Medical Association, the American Osteopathic Association, the American Psychiatric Association, and the American Dental Association. These entities may apply alone or as a consortium; if applying as a consortium, one organization must serve as the legal applicant and accept responsibility for the grant, and the application must include a signed written agreement detailing each partner's roles and responsibilities.
Overall, the opportunity is a targeted federal effort to reduce opioid-related harm by strengthening clinical practice at the point of prescribing and treatment. Rather than funding direct patient services, the grant invests in a national mentorship and consultation backbone designed to help clinicians apply evidence-based opioid prescribing and addiction-treatment practices, address misconceptions and quality concerns surrounding methadone and OTPs, and ultimately curb prescription opioid misuse, diversion, and preventable overdose deaths.
Frequently Asked Questions (FAQs)
What is this grant opportunity?
This is a FY 2011 SAMHSA/CSAT discretionary cooperative agreement (TI-11-007) to create a free, nationwide Prescriber's Clinical Support System focused on the appropriate use of opioids in chronic pain care and opioid-related addiction treatment.
What is the main goal of the funded project?
The main goal is to build a national mentoring and clinical support network that clinicians can use for practical help, including current clinical updates, case-based consultations, training, and dissemination of evidence-based outcomes and practices, with the larger public health intent of reducing opioid-related misuse, diversion, adverse events, and deaths.
What does "PCSS Opioids" mean in this announcement?
It refers to the Prescriber's Clinical Support System focused on opioids. In this funding announcement, it is described as a free, nationwide clinical support system for prescribers and other clinicians dealing with opioid prescribing for pain and opioid-related addiction treatment.
Is the support system intended to be free to clinicians?
Yes. The announcement describes the project as creating a free, nationwide system that clinicians can access for mentoring, training, and clinical support.
What types of support are expected to be provided to clinicians?
The announcement emphasizes practical, clinician-facing support, including current clinical updates, case-based consultations, training, and dissemination of evidence-based outcomes and practices.
Is the grant intended to fund direct patient services?
No. The opportunity is positioned as investing in a national mentorship and consultation backbone to strengthen clinical practice rather than funding direct patient services.
Why did SAMHSA create this opportunity?
SAMHSA frames the opportunity as a response to rising opioid-related morbidity and mortality (including fatal drug interactions) and to the growing volume of opioid prescribing over the prior decade. It also highlights concerns that many clinicians have limited formal training and limited access to ongoing mentoring, continuing education, and real-time clinical support for complex opioid-related care decisions.
How does this grant relate to methadone?
Methadone is highlighted as a major driver in the announcement due to concerns about methadone-related deaths and the public narrative around their increase. SAMHSA notes that available data suggest much of the increase in methadone-associated mortality is linked to rapid growth in methadone prescribing for chronic pain, while public perception often blames diversion from opioid treatment programs (OTPs) or poor care within some OTPs.
Is the program only about methadone?
No. The announcement explicitly states the effort is broader than methadone alone and references rising misuse of other prescription opioids such as oxycodone, hydrocodone, fentanyl, and oxymorphone.
Which opioid-related settings are included (pain care vs. addiction treatment)?
The support system is focused on appropriate opioid use in both chronic pain care and opioid-related addiction treatment, including clinicians working in SAMHSA-certified opioid treatment programs (OTPs) and prescribers providing opioid-based therapy for chronic pain.
Who is the intended audience for the support system?
The target audience includes physicians and dentists, as well as other health professionals involved in opioid prescribing and care, including clinicians working in SAMHSA-certified OTPs and prescribers treating chronic pain with opioid-based therapy.
What national problem is this program trying to address?
It is aimed at reducing opioid-related harms, including misuse, diversion, adverse events, and preventable overdose deaths, in the context of increasing opioid prescribing and rising opioid-related morbidity and mortality.
What is SAMHSA's position on methadone maintenance treatment in this announcement?
SAMHSA emphasizes that methadone maintenance treatment has strong scientific support as an effective treatment for opioid addiction and expresses concern that misperceptions about methadone deaths could undermine confidence in methadone maintenance.
Where does SAMHSA place this program within its broader strategy?
The announcement positions the program within SAMHSA's Prevention of Substance Abuse and Mental Illness Strategic Initiative and notes alignment with Healthy People 2020 focus area 40 (Substance Abuse).
Does the announcement mention coordination with other federal or state entities?
Yes. It references broader interagency collaboration on opioid harms, including coordination with the Office of National Drug Control Policy, CDC, DEA, NIDA, FDA, and state agencies.
What type of award is this?
It is a discretionary cooperative agreement.
How many awards does SAMHSA expect to make?
The announcement states an expected single award.
What is the estimated total funding amount?
The estimated total funding is $500,000.
What is the award ceiling?
The award ceiling is $500,000.
Is cost-sharing or matching required?
No. The announcement states there is no cost-sharing or matching requirement.
What are the key dates listed for this opportunity?
Posted date: March 9, 2011. Application closing date: April 19, 2011. Archive date: May 19, 2011.
What is the CFDA number for this opportunity?
The CFDA number is 93.243 (Substance Abuse and Mental Health Services - Projects of Regional and National Significance).
Who is eligible to apply?
Eligibility is limited to the following organizations: the American Society of Addiction Medicine, the American Academy of Addiction Psychiatry, the American Medical Association, the American Osteopathic Association, the American Psychiatric Association, and the American Dental Association.
Why is eligibility limited to a small set of organizations?
SAMHSA states the eligibility is deliberately narrow because it needs to move quickly with organizations that already have the reach, infrastructure, and credibility to educate large numbers of prescribers.
Can eligible organizations apply as a consortium?
Yes. The eligible entities may apply alone or as a consortium.
If applying as a consortium, what is required?
If applying as a consortium, one organization must serve as the legal applicant and accept responsibility for the grant. The application must include a signed written agreement that details each partner's roles and responsibilities.
What scale of effort is SAMHSA expecting?
The project is expected to stand up a national infrastructure that can deliver training and consultation at a scale appropriate for a national public health response.
What sources does SAMHSA cite to support the need for this work?
The announcement references national surveillance sources such as the National Survey on Drug Use and Health and the Drug Abuse Warning Network to underscore rising misuse of prescription opioids.
What kinds of opioids are specifically mentioned in the announcement?
In addition to methadone, the announcement mentions oxycodone, hydrocodone, fentanyl, and oxymorphone as examples of other prescription opioids associated with rising misuse.
What clinical challenges does the program aim to help clinicians with?
The announcement notes that assessing patients for opioid therapy, managing risk, and delivering opioid-based treatment safely are complex tasks, and that many clinicians lack formal training and access to mentoring and real-time clinical support. The program is intended to address those gaps.
What is the overall intended impact of the PCSS Opioids effort?
The intended impact is to strengthen clinical decision-making and prescribing practices using evidence-based guidance and support, and in turn reduce misuse, diversion, adverse events, and opioid-related deaths.
Browse more opportunities from the same category: Health
Next opportunity: Department of Defense Explosive Ordnance Disposal (EOD) (previously referred to as Joint Service EOD)
Previous opportunity: Systematics and Biodiversity Science
USGrants.org Applicant Portal:
Are you interested in learning about about how to apply for this government funding opportunity? You can create a free applicant account and receive instant access to our applicant portal that many business owners like you have benefited from.
Apply for TI 11 007
[Watch] how do funding administrators access proposals?
Applicants also applied for:
Applicants who have applied for this opportunity (TI 11 007) also looked into and applied for these:
| Funding Opportunity |
|---|
| Circles of Care V Infrastructure Development for Children s Mental Health Systems in American Indian/Alaska Native (AI/AN) Communities Apply for SM 11 007 Funding Number: SM 11 007 Agency: Substance Abuse Mental Health Services Adminis. Category: Health Funding Amount: $311,140 |
| Strategic Prevention Framework State Prevention Enhancement Grants Apply for SP 11 004 Funding Number: SP 11 004 Agency: Substance Abuse Mental Health Services Adminis. Category: Health Funding Amount: $600,000 |
| Cooperative Agreements to Benefit Homeless Individuals (Short Title CABHI) Apply for TI 11 008 Funding Number: TI 11 008 Agency: Substance Abuse Mental Health Services Adminis. Category: Health Funding Amount: $500,000 |
| Grants to Develop and Expand Behavioral Health Treatment Court Collaboratives (Short Title Adult Treatment Court Collaboratives) Apply for TI 11 010 Funding Number: TI 11 010 Agency: Substance Abuse Mental Health Services Adminis. Category: Health Funding Amount: $400,000 |
| National Child Traumatic Stress Initiative Combined RFA Treatment and Service Adaptation Centers Category II and the Community Treatment and Services Centers Category III Apply for SM 11 011 Funding Number: SM 11 011 Agency: Substance Abuse Mental Health Services Adminis. Category: Health Funding Amount: $600,000 |
| Minority AIDS Initiative Targeted Capacity Expansion (MAI TCE) Integrated Behavioral Health/Primary Care Network Cooperative Agreements Apply for SM 11 006 Funding Number: SM 11 006 Agency: Substance Abuse Mental Health Services Adminis. Category: Health Funding Amount: $1,500,000 |
| Building capacity of the Pasteur Institute to provide quality laboratory diagnosis and surveillance of opportunistic infections related to HIV in the Republic of Cote d'Ivoire under the President’s Emergency Plan for AIDS Relief Apply for CDC RFA PS10 10370501SUPP16 Funding Number: CDC RFA PS10 10370501SUPP16 Agency: HHS-CDC Category: Health Funding Amount: $1,000,000 |
| Evaluating Locally-Developed or Adapted (Homegrown) Combination HIV Prevention Interventions for Transgender Persons who have Sex with Men Apply for RFA PS 16 003 Funding Number: RFA PS 16 003 Agency: HHS-CDC-HHSCDCERA Category: Health Funding Amount: $200,000 |
| Grants to States to Support Oral Health Workforce Activities Apply for HRSA 16 038 Funding Number: HRSA 16 038 Agency: HHS-HRSA Category: Health Funding Amount: Case Dependent |
| Supporting the Implementation and Expansion of High Quality, Sustainable and Comprehensive HIV Prevention, Care and Treatment Programs in the Eastern South Region and Nairobi County of the Republic of Kenya under the President’s Emergency Plan for Apply for CDC RFA GH16 1701 Funding Number: CDC RFA GH16 1701 Agency: HHS-CDC-CGH Category: Health Funding Amount: $22,000,000 |
| Capacity Building and Strengthening Implementation of HIV Combination Prevention and Treatment Services in Priority Geographic Locations and Populations at Facility, Community, District and Provincial Levels in the Republic of Zambia under the Presid Apply for CDC RFA GH16 1670 Funding Number: CDC RFA GH16 1670 Agency: HHS-CDC-CGH Category: Health Funding Amount: $20,000,000 |
| Emerging Infections Sentinel Networks (EISN) Research Apply for RFA CK 16 001 Funding Number: RFA CK 16 001 Agency: HHS-CDC-HHSCDCERA Category: Health Funding Amount: Case Dependent |
| Provision of Comprehensive HIV Care, Treatment, and Support Programs in the United Republic of Tanzania under the President’s Emergency Plan for AIDS Relief (PEPFAR) Apply for CDC RFA GH16 1653 Funding Number: CDC RFA GH16 1653 Agency: HHS-CDC-CGH Category: Health Funding Amount: $9,422,167 |
| Suicide Prevention Lifeline Crisis Center Follow-Up Apply for SM 16 006 Funding Number: SM 16 006 Agency: HHS-SAMHS Category: Health Funding Amount: $115,000 |
| Accelerating the Scale-Up of Voluntary Medical Male Circumcision for HIV Prevention for Maximum Public Health Impact in the United Republic of Tanzania under the President’s Emergency Plan for AIDS Relief (PEPFAR) Apply for CDC RFA GH16 1647 Funding Number: CDC RFA GH16 1647 Agency: HHS-CDC-CGH Category: Health Funding Amount: $9,000,000 |
| Statewide Consumer Network Program Apply for SM 16 002 Funding Number: SM 16 002 Agency: HHS-SAMHS Category: Health Funding Amount: $95,000 |
| Shared Instrumentation Grant (SIG) Program (S10) Apply for PAR 16 054 Funding Number: PAR 16 054 Agency: HHS-NIH11 Category: Health Funding Amount: $600,000 |
| Ryan White HIV/AIDS Program Integrated HIV Planning Implementation Apply for HRSA 16 082 Funding Number: HRSA 16 082 Agency: HHS-HRSA Category: Health Funding Amount: Case Dependent |
| Supporting the Ministry of Health, County Health Management Teams, and Service Delivery Partners in Developing and Maintaining Health Information Systems Innovations in the Republic of Kenya under the President’s Emergency Plan for AIDS Relief (PEP Apply for CDC RFA GH16 1628 Funding Number: CDC RFA GH16 1628 Agency: HHS-CDC-CGH Category: Health Funding Amount: $5,000,000 |
| Cooperative Agreement for the Provider’s Clinical Support System - Medication Assisted Treatment (Short Title: PCSS-MAT) Apply for TI 16 003 Funding Number: TI 16 003 Agency: HHS-SAMHS Category: Health Funding Amount: $1,000,000 |
Grant application guides and resources
It is always free to apply for government grants. However the process may be very complex depending on the funding opportunity you are applying for. Let us help you!
Apply for Grants
Premium leads for funding administrators, grant writers, and loan issuers
Thousands of people visit our website for their funding needs every day. When a user creates a grant proposal and files for submission, we pass the information on to funding administrators, grant writers, and government loan issuers.
If you manage government grant programs, provide grant writing services, or issue personal or government loans, we can help you reach your audience.
Subscribe to Leads
Request more information:
Would you like to learn more about this funding opportunity, similar opportunities to "TI 11 007", eligibility, application service, and/or application tips? Submit an inquiry below:
Don't forget to subscribe to our grant alerts mailing list to receive weekly alerts on new and updated grant funding opportunities like this one in your email.